We are live on ! Find out more
CFA

Carroll Financial Associates Portfolio holdings

AUM $1.88B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+20.52%
3 Year Est. Return
+80.57%
5 Year Est. Return
+102.34%
10 Year Est. Return
AUM
$1.15B
AUM Growth
+$81.1M
Cap. Flow
+$48.1M
Cap. Flow %
4.19%
Top 10 Hldgs %
48.81%
Holding
1,814
New
287
Increased
511
Reduced
261
Closed
62
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
851
Broadridge
BR
$19B
$18K ﹤0.01%
142
+3
+2% +$361
CHE icon
852
Chemed
CHE
$7.22B
$18K ﹤0.01%
50
IDLV icon
853
Invesco S&P International Developed Low Volatility ETF
IDLV
$348M
$18K ﹤0.01%
558
+1
+0.2% +$33
LOPE icon
854
Grand Canyon Education
LOPE
$3.98B
$18K ﹤0.01%
156
+15
+11% +$1.79K
LUMN icon
855
Lumen
LUMN
$6.44B
$18K ﹤0.01%
1,566
+810
+107% +$9.11K
LW icon
856
Lamb Weston
LW
$7.19B
$18K ﹤0.01%
286
NTRS icon
857
Northern Trust
NTRS
$33.9B
$18K ﹤0.01%
204
PCN
858
PIMCO Corporate & Income Strategy Fund
PCN
$885M
$18K ﹤0.01%
1,080
PRLB icon
859
Protolabs
PRLB
$2.13B
$18K ﹤0.01%
159
RELX icon
860
RELX
RELX
$62B
$18K ﹤0.01%
778
+121
+18% +$2.78K
SPG icon
861
Simon Property Group
SPG
$72.3B
$18K ﹤0.01%
117
+8
+7% +$1.38K
SYF icon
862
Synchrony
SYF
$25.6B
$18K ﹤0.01%
+524
New +$17.8K
TYL icon
863
Tyler Technologies
TYL
$12.8B
$18K ﹤0.01%
85
+24
+39% +$5.21K
GWPH
864
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$18K ﹤0.01%
106
AIMT
865
DELISTED
Aimmune Therapeutics
AIMT
$18K ﹤0.01%
910
-645
-41% -$13.3K
ADI icon
866
Analog Devices
ADI
$190B
$17K ﹤0.01%
159
-17
-10% -$1.84K
AVNT icon
867
Avient
AVNT
$4.19B
$17K ﹤0.01%
+543
New +$15.2K
DRI icon
868
Darden Restaurants
DRI
$24.4B
$17K ﹤0.01%
145
+55
+61% +$6.54K
ETV
869
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.76B
$17K ﹤0.01%
1,175
-965
-45% -$14.3K
HDB icon
870
HDFC Bank
HDB
$121B
$17K ﹤0.01%
544
+116
+27% +$3.5K
PFG icon
871
Principal Financial Group
PFG
$24.3B
$17K ﹤0.01%
300
+200
+200% +$11K
SAIC icon
872
Saic
SAIC
$5.35B
$17K ﹤0.01%
202
SPYG icon
873
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.4B
$17K ﹤0.01%
446
TAP icon
874
Molson Coors Class B
TAP
$8.09B
$17K ﹤0.01%
316
+3
+1% +$175
TECH icon
875
Bio-Techne
TECH
$11.3B
$17K ﹤0.01%
336
+36
+12% +$1.81K

Similar funds

Carroll Financial Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Carroll Financial Associates held 1,814 positions worth $1.15B, up 7.6% from $1.07B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Carroll Financial Associates deployed $48.1M of net new capital in Q2 2019, opening 287 new positions and adding to 511 existing holdings. Its largest new stake was State Street SPDR Portfolio Short Term Treasury ETF: 368,957 shares worth $11.1M.

By sector, the portfolio is most concentrated in Financials at 6.8% of assets, up from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 400 Mid Cap ETF, an estimated $22.5M trimmed.

  • Carroll Financial Associates's largest Q2 2019 buy was State Street SPDR Portfolio Short Term Treasury ETF: 368,957 shares worth $11.1M.
  • Carroll Financial Associates added most to iShares 3-7 Year Treasury Bond ETF in Q2 2019, an estimated $20.5M increase.
  • Carroll Financial Associates's biggest Q2 2019 reduction was State Street SPDR Portfolio S&P 400 Mid Cap ETF, cutting an estimated $22.5M.
  • Carroll Financial Associates fully exited DuPont de Nemours in Q2 2019, selling an estimated $4.07M.
  • Carroll Financial Associates's ten largest holdings make up 49% of its $1.15B portfolio in Q2 2019.
  • Carroll Financial Associates opened 287 new positions and closed 62 in Q2 2019.
  • Carroll Financial Associates's portfolio value rose 7.6% quarter-over-quarter to $1.15B.

Based on Carroll Financial Associates's 13F filing for Q2 2019, filed 8 Jul 2019.